Ken Griffin Nexalin Technology, Inc. Transaction History

Citadel Advisors LLC

  • $550 Billion
  • Q2 2025

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Nexalin Technology, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 37,289 shares of NXL stock, worth $31,695. This represents 0.0% of its overall portfolio holdings.

Number of Shares
37,289
Holding current value
$31,695
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
BUY
$0.92 - $2.01 $34,305 - $74,950
37,289 New
37,289 $36,000
Q3 2024

Nov 14, 2024
BUY
$0.66 - $1.66 $38,402 - $96,587
58,185 New
58,185 $38,000
Q3 2023

Nov 14, 2023
BUY
$0.38 - $0.95 $5,718 - $14,295
15,048 New
15,048 $6,000
Q3 2022

Nov 14, 2022
BUY
$1.08 - $2.25 $16,719 - $34,832
15,481 New
15,481 $17,000

Others Institutions Holding NXL

# of Institutions
22
Shares Held
1.36M
Call Options Held
0
Put Options Held
0
View Full List

About Nexalin Technology, Inc.

NXL Quotes by TradingView
  • Ticker NXL
  • Exchange
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 7,279,960
  • Market Cap $6.19M
More about NXL
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email